Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × NSCLC × HMPL-013 × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 2 NSCLC 1 HER2-positive Colorectal Cancer 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Advanced Malignancies 1 Advanced Colorectal Cancer 1

Interventions

osimertinib 3 Vinorelbine 3 Pemetrexed 3 Cisplatin 3 Carboplatin 3 Gemcitabine 2 Docetaxel 2 CP protocol 2 pembrolizumab 1 aumolertinib 1 Taxes 1 Paclitaxel 1 HMPL-013 1 HM781-36B 1 Gefitinib 1 Erlotinib Hydrochloride 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02691299 2019-02-12

FALUCA

Hutchmed

Phase 3 Completed

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡